IPP Bureau
Redcliffe Labs appoints Vijay T. S. as Chief People Officer
By IPP Bureau - June 01, 2026
Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments
Zydus’ Saroglitazar wins FDA priority review after strong Phase 3 results in liver disease trial
By IPP Bureau - June 01, 2026
The therapy also delivered significant improvements in key liver enzyme markers
National Policy Dialogue adopts landmark 10-point declaration for people with disabilities
By IPP Bureau - June 01, 2026
World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection
Samsung Bioepis launches Aflibercept biosimilar OPUVIZ across Europe
By IPP Bureau - June 01, 2026
The aflibercept biosimilar, referencing Eylea, becomes the company’s fifth directly commercialized biosimilar in Europe, expanding access to ophthalmology treatments
Pfizer and Innovent Biologics strike $10 billion cancer drug deal
By IPP Bureau - June 01, 2026
This alliance, covering up to 12 antibody drugs, highlights the growing trend of large-scale collaborations between Chinese biotech firms and global pharmaceutical giants
FDA clears Cercare Medical’s CBCT perfusion technology for real-time stroke imaging
By IPP Bureau - June 01, 2026
The technology enables clinicians to assess brain tissue and microvascular reperfusion directly in the angiography suite, potentially improving stroke treatment decisions and patient outcomes
Europe Treponema pallidum tests market to grow at 3% CAGR through 2036
By IPP Bureau - June 01, 2026
Increasing syphilis cases, stronger STI surveillance initiatives, and growing emphasis on early diagnosis are expected to support sustained demand
Clariant bags FDA nod for bio-based PVC additives
By IPP Bureau - June 01, 2026
Derived from rice bran wax, Licocare RBW products offer a renewable solution with a substantially lower carbon footprint than conventional montan waxes
Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
By IPP Bureau - June 01, 2026
The approval marks a major milestone in the global fight against antimicrobial resistance
Pfizer’s BRAFTOVI combo doubles progression-free survival in aggressive colorectal cancer trial
By IPP Bureau - June 01, 2026
The results confirm the study’s primary endpoint of objective response rate and now deliver a striking signal in progression-free survival
Pfizer’s drug combo shows strong survival results in aggressive prostate cancer trial
By IPP Bureau - June 01, 2026
This marks one of the most closely watched oncology readouts at this year’s medical congress
International scientists say deuterium research could reshape medicine
By IPP Bureau - June 01, 2026
The conference highlighted research suggesting that deuterium levels may influence key biological processes
Dr. Morepen partners with VIT Bhopal to launch integrated on-campus health centre
By IPP Bureau - June 01, 2026
The company plans to establish similar healthcare centres across universities, schools, and corporate campuses nationwide
MediElaj raises $100K to set up AI-powered healthcare kiosks in underserved regions
By IPP Bureau - June 01, 2026
The company is building a connected healthcare ecosystem that utilises smart healthcare kiosk and mobile app to deliver at-home, AI-assisted health screenings and non-invasive health measurements
Pfizer and FITT IIT Delhi identify 20 health startups under innovation programme
By IPP Bureau - June 01, 2026
Selected ventures to receive grants and structured intellectual property support to strengthen protection and management of healthcare innovations
